




• The global Gram-positive Bacterial Infection Drugs market size was valued at US$ 16.84 billion in 2024 and is projected to reach US$ 22.37 billion by 2030, at a CAGR of 4.9% during the forecast period 2024-2030.

• United States Gram-positive Bacterial Infection Drugs market size was valued at US$ 5.51 billion in 2024 and is projected to reach US$ 7.12 billion by 2030, at a CAGR of 4.4% during the forecast period 2024-2030.


